
|Articles|October 1, 2002
Supplements and Featured Publications
- New Directions for Type 2 Diabetes Mellitus Management
- Volume 8
- Issue 16 Suppl
Thiazolidinediones in the Treatment of Managed Care Patients with Type 2 Diabetes
Advertisement
Articles in this issue
about 23 years ago
Participating Facultyabout 23 years ago
New Directions for Type 2 Diabetes Mellitus ManagementNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
2
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
3
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5















































